glp 1 switzerland Are GLP-1 weight-loss drugs quietly reshaping how people eat? Could reduced appetite and smaller portion sizes change the future of food innovation? And what does this shift mean for the growing role Can Swiss pharma giant Roche

Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

They reduce appetite (a positive for those seeking weight loss)

The name GLP-1 receptor agonist may feel like a mouthful, so its not surprising everyones taken to calling everything Ozempic

Ozempic starts to break down at 86F / 30C

Upper Arm: The side or back of the upper arm can be used for subcutaneous injections, which are less common but may be a suitable alternative for some patients

doi: 10.1186/1475-2891-12-87 190 UpadhyayaS.BanerjeeG